Vasculitis treatment (Vasculitis management)

Specialist-led treatment to switch off the inflammation of blood vessels in vasculitis, protect organs, and then keep the condition under control over the long term.

✓ Medically reviewed by a GMC-registered consultant · last reviewed September 2026 · next review September 2027 · how we review

In short

Vasculitis is inflammation of blood vessels; some types are mild, but others can threaten organs or eyesight and need urgent treatment.
Treatment usually comes in two stages — switching off inflammation quickly, then keeping it under control long term — often using a course of steroids plus other medicines.
In giant cell arteritis, new visual symptoms or sudden sight loss are an emergency: seek urgent help, as sight loss can be permanent.
Immune-suppressing treatment raises the risk of infection, so monitoring and prompt reporting of fevers or feeling very unwell are essential.

A plain-English summary. The detail — including risks and recovery — is below.

At a glance

TypeMedical treatment (medicines and monitoring)

AnaestheticNot needed

How long it takesOngoing; often an intensive phase, then long-term control

Hospital stayMay need a hospital stay for severe disease or infusions

Time off workOften needed during active disease and intensive treatment

When you'll see resultsInflammation can settle within weeks; staying in remission is a long-term aim

On the NHS?Usually managed on the NHS by a specialist team; private care is mainly for speed or a specialist opinion

A general guide. Your specialist will give you advice for your situation.

Best fit

Can switch off blood-vessel inflammation, often within weeks

Pause if

Some strong immune-suppressing medicines are unsafe during active infection until it is treated.

Main recovery point

Steroids often improve symptoms quickly. In giant cell arteritis, prompt steroids aim to protect vision. Close monitoring checks the disease is responding...

Good aftercare

A clear, staged treatment plan with a written steroid-reduction schedule and a steroid card.

First days to weeks

Steroids often improve symptoms quickly. In giant cell arteritis, prompt steroids aim to protect vision. Close...

First few months (induction)

Stronger medicines work to bring the disease fully under control. This phase can be demanding and may need time...

Moving to maintenance

Once in remission, treatment is changed to gentler medicines and steroids are gradually reduced, with continued...

Long term

Maintenance treatment often continues for a few years. Some people can eventually reduce or stop medicines under...

Medical line illustration of immunology and autoimmune pathways for Vasculitis treatment. — Illustration only - not a diagnosis, medical advice or a promise of result. Your anatomy and treatment plan may differ. Vuemedics does not publish before-and-after photos.

What is vasculitis treatment?

Vasculitis means inflammation of blood vessels. When vessels become inflamed, they can narrow, weaken or block, reducing blood flow to the tissues and organs they supply. There are many types of vasculitis, affecting vessels of different sizes and different parts of the body, so the symptoms and treatment vary a great deal.

Some types mainly affect the skin and are relatively mild. Others, such as ANCA-associated vasculitis (which includes granulomatosis with polyangiitis), can affect the kidneys, lungs, nerves and other organs and can be life- or organ-threatening if not treated promptly. Giant cell arteritis, a vasculitis of larger arteries in older adults, can threaten eyesight and needs urgent treatment.

Treatment usually has two stages. The first switches off the inflammation quickly, typically with steroids (sometimes high-dose) alongside other immune-suppressing medicines or biologics. The second, gentler stage keeps the disease in remission over the longer term while reducing medicine side effects.

Because vasculitis can be serious and complex, it is best managed by a specialist team. A key aim is to treat quickly enough to protect organs and, in giant cell arteritis, eyesight, while watching carefully for relapses and for side effects of treatment, especially infection.

Types, options & approaches

There may be different ways to do this. The right approach depends on the clinical question and your circumstances.

Steroids (corticosteroids)

Steroids such as prednisolone are highly effective at switching off vessel inflammation and are usually central to early treatment, sometimes given in high doses or into a vein for severe disease, then reduced over time.

Induction (getting control)

The first, more intensive stage uses steroids with a stronger immune-suppressing medicine (such as cyclophosphamide or rituximab in ANCA-associated vasculitis) to bring active disease under control quickly.

Maintenance (keeping control)

Once inflammation is controlled, gentler immune-suppressing medicines (such as azathioprine, methotrexate or mycophenolate) are used to keep the disease in remission with fewer side effects.

Giant cell arteritis treatment

Treated urgently with steroids — often started before tests are complete — to protect eyesight, with a steroid-sparing medicine (such as tocilizumab) sometimes added and a long, gradual steroid reduction.

Biologic and targeted treatments

Targeted medicines (such as rituximab, tocilizumab or avacopan in selected ANCA-associated vasculitis) may be used to control disease or reduce reliance on steroids.

Protective and supportive care

Bone protection, infection prevention, blood pressure and kidney care and vaccinations support the main treatment, because both the disease and its medicines carry risks.

Getting control vs keeping control

	Induction phase	Maintenance phase
Main aim	Switch off inflammation quickly	Keep the disease in remission
Typical medicines	Steroids plus a strong immunosuppressant	Gentler immunosuppressant, lower steroid
Intensity	More intensive, closer monitoring	Less intensive, ongoing monitoring
Duration	Weeks to a few months	Often a few years, sometimes longer

The strong early treatment is needed to protect organs; the gentler later treatment reduces long-term side effects while preventing relapse.

Preparing for your treatment

List your symptoms and how quickly they have come on, as rapidly worsening symptoms can need urgent treatment.
Bring your current medicines, and mention any infections, recent vaccinations or past TB.
Expect blood and urine tests, and sometimes imaging or a biopsy, to confirm the type and extent of vasculitis.
Ask about bone protection, infection prevention and vaccinations before starting immune-suppressing treatment.
If you have headaches, scalp tenderness, jaw ache on chewing or any visual symptoms, say so straight away — these can signal giant cell arteritis.
Discuss fertility and pregnancy plans, as some strong medicines affect these and need planning.
Arrange support for time off, as the early phase of treatment can be demanding.

What happens

Your specialist works out which type of vasculitis you have, which vessels and organs are involved, and how active and severe it is, using your symptoms, examination, blood and urine tests, and often imaging or a biopsy. The urgency depends on the type — some forms, and giant cell arteritis in particular, are treated quickly to protect organs and eyesight.

Treatment usually begins with steroids to switch off inflammation, alongside a stronger immune-suppressing medicine or biologic for more serious disease. This induction phase is monitored closely. In giant cell arteritis, steroids are often started before all the test results are back, because of the risk to vision.

Once the disease is under control, treatment moves to a gentler maintenance phase to keep it in remission with fewer side effects, and steroids are slowly reduced. Throughout, you are monitored for relapse and for side effects, especially infection, with protective measures such as bone protection and vaccinations, and care shared with other specialists where organs are involved.

Is this treatment right for me?

A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.

May not be suitable if…

Some strong immune-suppressing medicines are unsafe during active infection until it is treated.
Certain medicines (for example cyclophosphamide) affect fertility and are not used lightly, especially in younger people, without discussion.
Some treatments are not safe in pregnancy and must be reviewed before conception.
Treatment intensity should match disease severity — strong induction treatment is not appropriate for very mild, localised disease.

Delay or rearrange if…

You have an active infection that should be treated before starting or increasing immune-suppressing medicines (urgent treatment may still be needed if the vasculitis itself is dangerous).
Fertility preservation needs arranging before certain medicines, where time allows.
Baseline tests are still awaited and would change the plan — though giant cell arteritis is often treated before results are back to protect vision.
You are pregnant or planning pregnancy and your medicines have not been reviewed.

Alternatives to discuss

Less intensive treatment for milder, skin-limited vasculitis without organ involvement.
Choosing between different induction or maintenance medicines based on your situation and side-effect profile.
Steroid-sparing or biologic medicines to reduce reliance on long-term steroids.
Supportive measures (bone protection, infection prevention, vaccinations) alongside the main treatment.

Before you decide

Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.

What matters most to me?

Think about symptoms, daily life, work, caring responsibilities, sport, fertility, travel, appearance and anxiety — the right choice depends on your priorities, not just the medical facts.

What are all my options?

Ask about waiting, monitoring, medicines, rehabilitation, a smaller or larger procedure, a different test, NHS referral, or a second opinion where that would help.

What would make me pause?

Active infection, pregnancy, unstable medical problems, smoking, medicines that increase bleeding, poor support at home, or feeling pressured are all reasons to slow down and get tailored advice.

What happens if I do nothing today?

For some problems, waiting is safe; for others, delay can make treatment harder. A good consultation should explain the trade-off in plain English.

Benefits

Can switch off blood-vessel inflammation, often within weeks
Protects organs such as the kidneys, lungs and nerves from damage
In giant cell arteritis, helps protect eyesight when started promptly
Keeps the disease in remission over the longer term
Allows steroid doses to be reduced as gentler medicines take over

Risks & complications

More common

Side effects of steroids such as weight gain, mood changes, raised blood sugar, bone thinning and disturbed sleep
A higher tendency to infections while on immune-suppressing treatment
Nausea, fatigue or other side effects from immune-suppressing medicines
The need for frequent blood and urine tests, especially early on

Less common

Needing to switch medicines because of side effects or because disease stays active
Reduced fertility with some strong medicines, which should be discussed beforehand
Bladder or blood-count effects from particular medicines, which monitoring is designed to catch

Rare but serious

Serious infections while immune-suppressed, sometimes needing hospital treatment
Permanent organ damage if disease is severe or treatment is delayed
Permanent sight loss in giant cell arteritis if treatment is not started in time

Vasculitis treatment balances two dangers: under-treating active disease, which can damage organs or eyesight, and the side effects of strong medicines, especially infection. The most time-critical situation is giant cell arteritis — any new visual symptoms or sudden sight loss is an emergency, because sight loss can be permanent. While on immune-suppressing treatment, report fevers or feeling very unwell promptly, and keep up bone protection and any preventive medicines.

Published figures to discuss

Vasculitis covers many different conditions, so outcomes and risks vary widely by type and severity, and reliable single percentages are limited. The key risks are organ or sight damage from active disease and infection from treatment. In giant cell arteritis specifically, untreated disease carries a significant risk of permanent sight loss, which is why prompt treatment matters.

Figure	Reported range	How to interpret it	Source / confidence
Permanent sight loss in untreated giant cell arteritis	Reported in up to around 1 in 5 people if untreated	Based on NHS information; sight loss is usually irreversible, which is why steroids are started urgently, often before tests are complete.	NHS — Vasculitisnhs.ukPublished figure
Relapse in ANCA-associated vasculitis	Common; many cohorts report relapse in roughly 30 to 50% over several years	Maintenance treatment and follow-up are used because remission does not mean the disease has gone forever.	NHS — Vasculitisnhs.ukPublished figure
Serious infection during induction immunosuppression	Uncommon to common depending on regimen, age and kidney/lung involvement	Infection prevention, vaccination review and prompt fever advice are central parts of vasculitis care.	NHS — Vasculitisnhs.ukSource-linked context
Organ damage before diagnosis	Clinically important and sometimes irreversible	Blood in urine, worsening kidney function, coughing blood, nerve weakness, new visual symptoms or purpura need urgent assessment.	NHS — Vasculitisnhs.ukSource-linked context

These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.

What happens afterwards

There is no physical recovery from the treatment itself. What matters is the disease response: inflammation can settle within weeks, but staying in remission and safely reducing medicines is a longer process managed with ongoing monitoring.

First days to weeks

Steroids often improve symptoms quickly. In giant cell arteritis, prompt steroids aim to protect vision. Close monitoring checks the disease is responding and treatment is tolerated.

First few months (induction)

Stronger medicines work to bring the disease fully under control. This phase can be demanding and may need time off and frequent tests.

Moving to maintenance

Once in remission, treatment is changed to gentler medicines and steroids are gradually reduced, with continued monitoring for relapse.

Long term

Maintenance treatment often continues for a few years. Some people can eventually reduce or stop medicines under specialist guidance, with ongoing watch for relapse.

What's normal — and not a worry

Quick early improvement from steroids, followed by a slower, longer phase
Temporary steroid side effects that ease as the dose is reduced
Tiredness during the intensive treatment phase
Ongoing need for blood and urine tests even when feeling better

Aftercare

Take all medicines exactly as prescribed and do not stop steroids suddenly — they must be reduced gradually.
Attend blood and urine tests so relapse and medicine side effects are caught early.
Watch for and report signs of infection promptly: fever, shivering or feeling very unwell.
Keep up bone protection, vaccinations and any preventive medicines your team advises.
Carry a steroid card if you are on steroids, and tell any healthcare professional you are taking them.
Seek urgent help for any new visual symptoms if you have, or are being assessed for, giant cell arteritis.
Report any return of your original symptoms, as this may signal a relapse.

Before your treatment

A clear list of medicines, doses and how to reduce steroids
A steroid card if you are taking steroids
Your next blood and urine tests booked
Bone protection and vaccinations arranged
Knowing the warning signs of relapse and of infection
An urgent contact route, especially for visual symptoms in giant cell arteritis

⚠ Get urgent help if…

New visual symptoms or sudden loss of vision if you have, or may have, giant cell arteritis — this is an emergency, seek help immediately
Signs of serious infection while immune-suppressed: high fever, shivering, feeling very unwell
Coughing up blood, or new or worsening breathlessness
Blood in the urine, frothy urine or much-reduced urine (possible kidney involvement)
New numbness, weakness or severe headache with scalp tenderness or jaw ache on chewing
Return of the symptoms that first led to your diagnosis (possible relapse)

Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.

General guidance — it doesn't replace the specific advice your specialist gives you.

Results & realistic expectations

A good result is the disease brought into remission — inflammation switched off and organs protected — and then kept under control on the lowest safe medicines, with steroids reduced over time. In giant cell arteritis, a key result is protecting eyesight by treating promptly.

Progress is judged over time by the specialist team using your symptoms, examination and tests, not by a single appointment. Reaching remission is the first goal; staying in remission while avoiding treatment side effects is the longer-term one. Some people relapse and need treatment stepped back up, which is part of managing the condition rather than a failure.

How long it lasts

Many types of vasculitis are long-term conditions that can relapse, so treatment and monitoring usually continue for years. Maintenance treatment is often given for a few years; some people can eventually reduce or stop medicines under specialist guidance, while others need longer-term treatment. Ongoing monitoring for relapse continues even after treatment is reduced.

Related tests, treatments or support

Vasculitis care often involves several specialists alongside the lead team — for example kidney specialists for kidney involvement, lung or ear-nose-throat specialists, ophthalmologists in giant cell arteritis, and neurologists for nerve involvement. Bone health, infection prevention, blood pressure and vaccinations are managed alongside the main treatment.

Follow-up & long-term care

You will be reviewed regularly, with blood and urine tests to detect relapse and monitor medicines. Reviews are more frequent during the intensive phase and as steroids are reduced, then spaced out once stable. Any return of symptoms, or new organ or visual symptoms, prompts earlier assessment, and care is coordinated with other specialists as needed.

Maintenance immune-suppressing medicine, often for a few years
Gradual, supervised reduction of steroids — never stopped suddenly
Regular blood and urine tests to detect relapse and side effects
Bone protection, vaccinations and infection-prevention measures
Ongoing watch for relapse, including after treatment is reduced or stopped

Repeat, follow-on and what comes next

Treatment commonly moves through phases — intensive induction, then maintenance — rather than a single fixed course.
Some people relapse and need treatment stepped back up; this is part of managing the condition.
Medicines are often switched to balance disease control against side effects, especially to reduce long-term steroids.

Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.

What good aftercare looks like

A clear, staged treatment plan with a written steroid-reduction schedule and a steroid card.
Regular blood and urine monitoring for relapse and side effects, with a named urgent contact.
Bone protection, vaccinations and infection-prevention measures in place.
Coordinated care with kidney, lung, eye or nerve specialists, and clear emergency advice for visual symptoms in giant cell arteritis.

What affects the cost

Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:

Specialist consultation fees and how many follow-up appointments are needed
Tests to diagnose and stage the disease, including blood and urine tests, imaging and sometimes a biopsy
Strong induction medicines and biologics (such as rituximab), which can be costly, and their monitoring
Infusions and any hospital stays during intensive treatment
Ongoing maintenance medicines and regular monitoring tests
Input from other specialists, such as kidney, lung, eye or nerve specialists, when organs are involved

Make sure your written quote includes

The consultation fee and the expected number of follow-up visits
The cost of diagnostic tests, imaging and any biopsy
The cost of induction and biologic medicines, infusions and any hospital stay
The cost and frequency of ongoing monitoring blood and urine tests
What happens, and what it costs, during a relapse or serious complication
How care is coordinated with the other specialists you may need

On the NHS? Vasculitis is usually managed on the NHS by a specialist team, and severe disease may need hospital treatment; private care is mainly used for faster access or a specialist opinion.

You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.

Choosing a specialist safely

Check the specialist is on the GMC Specialist Register for this area.
Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
You're entitled to your total cost in writing — including any follow-up — before you decide.

How Vuemedics verifies every consultant →

Questions to ask your medical professional

Take this to your consultation. A good specialist will welcome every one of these.

Which type of vasculitis do I have, and which organs are involved?
What does my early (induction) treatment involve, and how long will it last?
How will my steroids be reduced, and what side effects should I watch for?
What are the warning signs of a relapse I should act on?
If giant cell arteritis is possible, what should I do about visual symptoms?
What can I do to reduce my risk of infection while on treatment?
Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
Will you be the specialist who carries out my treatment, and who looks after me afterwards?
What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
What does a realistic result look like — and what can this treatment not achieve?
What are my options, including waiting, doing nothing for now, or choosing a different approach?
Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
What is the total cost in writing, including any follow-ups, and how much time do I have to decide?

Frequently asked questions

Can vasculitis be treated on the NHS?

Yes. It is usually managed on the NHS by a specialist team, often with several specialists involved, and may need hospital treatment for severe disease. Private care is mainly used for faster access or a specialist opinion.

Why do I need such strong treatment at first?

Some types of vasculitis can damage organs quickly, so strong early treatment is used to switch off the inflammation fast and protect organs. Once controlled, treatment is usually changed to gentler medicines.

Why can't I stop my steroids suddenly?

Steroids must be reduced gradually because the body needs time to adjust, and stopping suddenly can be dangerous. Your team will give you a step-by-step reduction plan and a steroid card.

What should I do about my eyes if I have giant cell arteritis?

Treat any new visual symptoms or sudden loss of vision as an emergency and seek urgent help immediately, because sight loss in giant cell arteritis can be permanent. This is why steroids are started promptly.

Will my vasculitis come back?

Some types can relapse, which is why monitoring continues even when you feel well. If symptoms return, treatment can be stepped back up. Relapses are part of managing the condition, not a sign treatment has failed.

How do I reduce my risk of infection?

Keep up the vaccinations and preventive medicines your team advises, report fevers or feeling very unwell promptly, and tell other healthcare professionals you are on immune-suppressing treatment.

Find a verified specialist for vasculitis treatment

Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.

No verified consultants list this procedure yet — browse the full directory.

See all specialists for vasculitis treatment →

How we made this page

Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →

Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.

Sources & standards: NHS — Vasculitis NHS — Granulomatosis with polyangiitis (GPA) Vasculitis UK — Glossary of drugs and side effects Versus Arthritis — Vasculitis British Society for Rheumatology — ANCA-associated vasculitis guideline

Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.

Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.